Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study.

The great majority of the levamisole-related ADRs concerned its immunomodulatory indication and multiple-dose regimen. Our results suggest that single-dose treatments for anthelmintic action have a good safety profile.